![PDF) Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial PDF) Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial](https://i1.rgstatic.net/publication/299577568_Acute_renal_effects_of_the_GLP-1_receptor_agonist_exenatide_in_overweight_type_2_diabetes_patients_a_randomised_double-blind_placebo-controlled_trial/links/5726f8ef08ae262228b2175b/largepreview.png)
PDF) Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
![PDF) Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial PDF) Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial](https://www.researchgate.net/profile/Marcel_Muskiet/publication/299577568/figure/fig2/AS:941370621566984@1601451654154/Flow-diagram-of-study-participants_Q320.jpg)
PDF) Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
![http://sheekh-3arb.org/library/books/christian/en/FonlexikaLangenscheidtHebrewEnglish by sheekh 3arb - issuu http://sheekh-3arb.org/library/books/christian/en/FonlexikaLangenscheidtHebrewEnglish by sheekh 3arb - issuu](https://image.isu.pub/100822010121-1d361d098a6a446abbaae5cc4964576e/jpg/page_1.jpg)